BELITE BIO INC - AMERICAN DEPOSITARY SHARES
58.72
06-يناير-25 16:45:00
15 متأخرة بدقائق
الأسهم
-3.37
-5.43%
نطاق اليوم
58.09 - 62.10
ISIN
N/A
المصدر
NASDAQ
-
Belite Bio Announces $25 Million Registered Direct Offering
25 أبريل 2024 19:15:29 بحسب Nasdaq GlobeNewswire
-
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
22 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
11 مارس 2024 22:28:39 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
11 مارس 2024 21:27:47 بحسب Nasdaq GlobeNewswire
-
06 مارس 2024 08:00:01 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
04 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
07 فبراير 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
30 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Participate in the BTIG Ophthalmology Day
20 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results
13 نوفمبر 2023 20:15:47 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results
07 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
06 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
27 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
08 أغسطس 2023 22:17:28 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
04 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
27 يوليو 2023 17:00:00 بحسب Nasdaq GlobeNewswire
-
30 مايو 2023 20:49:26 بحسب Nasdaq GlobeNewswire
-
30 مايو 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports First-Quarter 2023 Operational Highlights and Financial Results
10 مايو 2023 19:58:59 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on May 11, 2023 to Discuss First Quarter 2023 Financial Results
10 مايو 2023 15:33:22 بحسب Nasdaq GlobeNewswire